|
🐜
|
Independent Impact of Iron Overload and Transfusion Dependency on Survival and Leukemic Evolution in Patients with Myelodysplastic Syndrome
32 auth.
G. Sanz,
B. Nomdedeu,
E. Such,
T. Bernal,
M. Belkaid,
M. Ardanaz,
V. Marco,
C. Pedro,
F. Ramos,
M. C. Cañizo,
E. Luño,
F. Cobo,
F. Carbonell,
V. Gómez,
J. Muñoz,
...
M. Amigo,
A. Bailén,
S. Bonanad,
M. Tormo,
R. Andreu,
B. Arrizabalaga,
M. Arilla,
J. Bueno,
M. Requena,
J. Bargay,
Joaquín Sánchez,
L. Senent,
L. Arenillas,
R. de Paz,
B. Xicoy,
R. Duarte,
J. Cervera
|
6 |
2008 |
6
🐜
|
|
🐜
|
Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia.
10 auth.
A. Sempere,
G. Sanz,
L. Senent,
J. delaRubia,
I. Jarque,
F. López,
...
M. Arilla,
M. Guinot,
G. Martín,
Joaquín Martínez
|
5 |
1992 |
5
🐜
|
|
🐜
|
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis
19 auth.
Pau Montesinos,
R. Rodríguez-Veiga,
B. Boluda,
D. Martínez-Cuadrón,
I. Cano,
Aima Lancharro,
J. Sanz,
M. Arilla,
F. López-Chuliá,
Inés Navarro,
...
I. Lorenzo,
M. Salavert,
Javier Pemán,
P. Calvillo,
J. Martínez,
N. Carpio,
I. Jarque,
Guillermo F. Sanz,
M. Sanz
|
5 |
2015 |
5
🐜
|
|
🐜
|
Bloodstream infections in adult patients undergoing cord blood transplantation from unrelated donors after myeloablative conditioning regimen.
17 auth.
J. Sanz,
I. Cano,
E. Gonzalez-Barbera,
M. Arango,
J. Reyes,
P. Montesinos,
I. Lorenzo,
I. Jarque,
Jesús A. Martínez,
F. López,
...
M. Arilla,
Aima Lancharro,
F. Moscardó,
J. López-Hontangas,
M. Salavert,
M. Sanz,
G. Sanz
|
5 |
2015 |
5
🐜
|
|
🐜
|
A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera.
15 auth.
J. Hernández-Boluda,
Arturo Pereira,
F. Cervantes,
A. Álvarez-Larrán,
M. Collado,
E. Such,
M. Arilla,
C. Boqué,
B. Xicoy,
M. Maffioli,
...
B. Bellosillo,
I. Marugán,
P. Amat,
C. Besses,
V. Guillem
|
5 |
2012 |
5
🐜
|
|
🐜
|
PROGNOSTIC VALUE OF CD34 EXPRESSION IN DE NOVO ACUTE MYELOBLASTIC LEUKAEMIA
7 auth.
M. Guinot,
G. Sanz,
A. Sempere,
M. Arilla,
I. Jarque,
F. Gomis,
...
M. Sanz
|
4 |
1991 |
4
🐜
|
|
🐜
|
Response to erythropoietic‐stimulating agents in patients with chronic myelomonocytic leukemia
31 auth.
B. Xicoy,
U. Germing,
M. Jiménez,
O. García,
R. García,
Jeniffer Schemenau,
C. Pedro,
E. Luño,
T. Bernal,
B. González,
C. Strupp,
M. Ardanaz,
A. Kuendgen,
M. Cedena,
J. Neukirchen,
...
M. Calabuig,
S. Brunet,
Á. Medina,
M. Amigo,
F. Ramos,
M. Callejas,
M. Díez-Campelo,
A. Bailén,
R. Collado,
A. Vicente,
M. Arnán,
D. Valcárcel,
M. Arilla,
L. Zamora,
L. Benlloch,
G. Sanz
|
4 |
2016 |
4
🐜
|
|
🐜
|
Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes
32 auth.
B. Xicoy,
M. Jiménez,
O. García,
J. Bargay,
V. Martínez‐Robles,
S. Brunet,
M. Arilla,
J. Pérez de Oteyza,
R. Andreu,
Francisco-Javier Casaño,
C. Cerveró,
A. Bailén,
M. Diez,
B. González,
A. Vicente,
...
C. Pedro,
T. Bernal,
E. Luño,
M. Cedena,
L. Palomera,
A. Simiele,
J. Calvo,
V. Marco,
E. Gómez,
M. Gómez,
D. Gallardo,
J. Muñoz,
R. de Paz,
J. Grau,
J. Ribera,
L. Benlloch,
G. Sanz
|
4 |
2014 |
4
🐜
|
